Hot Features
プレミアム
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Mr. Spencer S. StilesPresident & COO | -1.61k | 0.00 | Other Disposition | - | 77.72k | -2.03% |
| 2026-05-28 | Mr. Robert S. FletcherVP & Chief Legal Officer | -4.54k | 1.39M | Automatic Disposition | 304.23 - 310.22 | 10.77k | -29.68% |
| 2026-05-26 | Ms. Ronda E. StrykerIndependent Director | -310.00k | 96.79M | 売り | 310.77 - 315.11 | 14.82M | -2.05% |
| 2026-05-11 | Ms. M. Kathryn FinkVP & Chief HR Officer | -3.50k | 992.09k | 売り | 283.45 | 12.84k | -21.42% |
| 2026-05-08 | Ms. M. Kathryn FinkVP & Chief HR Officer | -21.58k | 2.67M | Derivative Exercise and Sale | 154.14 - 294.23 | 12.84k | - |
| 2026-03-21 | Mr. Spencer S. StilesPresident & COO | -430.00 | 144.34k | Derivative Exercise and Sale | 335.67 | 79.30k | - |
| 2026-03-21 | Mr. Spencer S. StilesPresident & COO | -6.26k | 2.10M | Sale to Issuer | 335.67 | 79.30k | -7.32% |
| 2026-03-21 | Mr. J. Andrew PierceGroup President of MedSurg & Neurotechnology | -430.00 | 144.34k | Derivative Exercise and Sale | 335.67 | 81.12k | - |
| 2026-03-21 | Mr. J. Andrew PierceGroup President of MedSurg & Neurotechnology | -7.38k | 2.48M | Sale to Issuer | 335.67 | 81.12k | -8.34% |
| 2026-03-21 | Mr. Viju S. MenonGroup President of Global Quality & Operations | -269.00 | 90.30k | Derivative Exercise and Sale | 335.67 | 17.58k | - |
| 2026-03-21 | Mr. Viju S. MenonGroup President of Global Quality & Operations | -4.45k | 1.49M | Sale to Issuer | 335.67 | 17.58k | -20.20% |
| 2026-03-21 | Mr. Kevin A. LoboChairman & CEO | -1.45k | 487.39k | Derivative Exercise and Sale | 335.67 | 222.95k | - |
| 2026-03-21 | Mr. Kevin A. LoboChairman & CEO | -25.04k | 8.41M | Sale to Issuer | 335.67 | 222.95k | -10.10% |
| 2026-03-21 | Mr. Robert S. FletcherVP & Chief Legal Officer | -225.00 | 75.53k | Derivative Exercise and Sale | 335.67 | 15.29k | - |
| 2026-03-21 | Mr. Robert S. FletcherVP & Chief Legal Officer | -3.16k | 1.06M | Sale to Issuer | 335.67 | 15.29k | -17.12% |
| 2026-03-21 | Ms. M. Kathryn FinkVP & Chief HR Officer | -150.00 | 50.35k | Derivative Exercise and Sale | 335.67 | 16.32k | - |
| 2026-03-21 | Ms. M. Kathryn FinkVP & Chief HR Officer | -1.91k | 642.47k | Sale to Issuer | 335.67 | 16.32k | -10.50% |
| 2026-03-21 | Mr. Preston W. WellsVP & CFO | -204.00 | 68.48k | Sale to Issuer | 335.67 | 6.79k | -2.92% |
| 2026-03-21 | Mr. Dylan B. CrottyGroup President of Orthopaedics | -368.00 | 123.53k | Sale to Issuer | 335.67 | 14.12k | -2.54% |
| 2026-03-21 | Mr. William E. BerryVP & CAO | -176.00 | 59.08k | Sale to Issuer | 335.67 | 1.23k | -12.49% |
| 2026-02-23 | Ms. Ronda E. StrykerIndependent Director | -55.60k | 0.00 | Other Disposition | - | 15.13M | -0.37% |
| 2026-02-13 | Ms. Ronda E. StrykerIndependent Director | -642.20k | 0.00 | Other Disposition | - | 15.18M | -4.06% |
| 2026-02-04 | Ms. Ronda E. StrykerIndependent Director | -500.00k | 181.72M | 売り | 358.51 - 368.56 | 15.82M | -3.06% |
| 2026-02-06 | Mr. Kevin A. LoboChairman & CEO | 74.55k | 7.20M | Derivative Exercise and Retained Stock | 96.64 | 197.66k | 60.55% |
| 2026-02-06 | Mr. Kevin A. LoboChairman & CEO | -132.41k | 35.19M | Derivative Exercise and Sale | 96.64 - 362.42 | 197.66k | - |
| 2026-02-03 | Mr. Spencer S. StilesPresident & COO | 6.15k | 594.14k | Derivative Exercise and Retained Stock | 96.64 | 70.65k | 9.53% |
| 2026-02-03 | Mr. Spencer S. StilesPresident & COO | -7.69k | 2.09M | Derivative Exercise and Sale | 96.64 - 368.14 | 70.65k | - |
| 2026-02-02 | Mr. J. Andrew PierceGroup President of MedSurg & Neurotechnology | 4.93k | 476.73k | Derivative Exercise and Retained Stock | 96.64 | 73.58k | 7.19% |
| 2026-02-02 | Mr. J. Andrew PierceGroup President of MedSurg & Neurotechnology | -8.91k | 2.43M | Derivative Exercise and Sale | 96.64 - 369.56 | 73.58k | - |
| 2026-01-15 | Mr. Andrew K. SilvernailIndependent Director | 3.34k | 322.87k | Derivative Exercise and Retained Stock | 96.64 | 12.69k | 35.74% |
| 2026-01-15 | Mr. Andrew K. SilvernailIndependent Director | -1.23k | 322.92k | Derivative Exercise and Sale | 96.64 - 359.39 | 12.69k | - |
| 2026-01-14 | Ms. Ronda E. StrykerIndependent Director | 4.57k | 441.64k | Derivative Exercise and Retained Stock | 96.64 | 16.32M | 0.03% |
| 2025-12-16 | Ms. M. Kathryn FinkVP & Chief HR Officer | -37.00 | 13.15k | Sale to Issuer | 355.31 | 13.01k | -0.28% |
| 2025-12-16 | Mr. William E. BerryVP & CAO | -28.00 | 9.95k | Sale to Issuer | 355.31 | 829.00 | -3.27% |
| 2025-11-21 | Mr. J. Andrew PierceGroup President of MedSurg & Neurotechnology | -211.00 | 0.00 | Other Disposition | - | 68.65k | -0.31% |
| 2025-11-20 | Mr. Preston W. WellsVP & CFO | -165.00 | 60.37k | 売り | 365.88 | 6.98k | -2.31% |
| 2025-11-14 | Mr. William E. BerryVP & CAO | -4.93k | 1.06M | Derivative Exercise and Sale | 154.14 - 373.42 | 613.00 | - |
| 2025-11-05 | Ms. Ronda E. StrykerIndependent Director | -520.00k | 184.61M | 売り | 349.95 - 359.79 | 16.32M | -3.09% |
| 2025-11-01 | Mr. Preston W. WellsVP & CFO | -404.00 | 143.92k | Sale to Issuer | 356.24 | 7.15k | -5.35% |
| 2025-08-25 | Mr. Viju S. MenonGroup President of Global Quality & Operations | -500.00 | 195.31k | 売り | 390.61 | 12.71k | -3.79% |
| 2025-08-20 | Mr. Robert S. FletcherVP & Chief Legal Officer | -1.79k | 701.63k | 売り | 393.07 | 10.62k | -14.39% |
| 2025-08-06 | Ms. Ronda E. StrykerIndependent Director | -200.00k | 75.29M | 売り | 374.99 - 381.13 | 16.84M | -1.17% |
| 2025-08-01 | Kimberly Ann Montagninoインサイダー | -155.00 | 60.87k | Sale to Issuer | 392.73 | 1.21k | -11.37% |
| 2025-08-01 | Mr. Robert S. FletcherVP & Chief Legal Officer | -441.00 | 173.19k | Sale to Issuer | 392.73 | 12.40k | -3.43% |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
